Hyun KA et al.[12] conducted a study on heterogeneous EpCAM expression in blood samples from breast cancer patients and provided additional evidence that decreased EpCAM expression is correlated with expression of both EMT and cancer stem cell markers. This evidence concerns the gene EPCAM and breast carcinoma.